Central Serous Retinopathy
Abstract
Background: Central Serous Retinopathy (CSR) is a localized well-circumscribed exudative detachment of sensory retina with or without detachment of the retinal pigment epithelium (RPE).1-5 The purpose of this write-up is to provide a concise up-to-date information on CSR.
Methods: The Internet was searched in English with Google Scholars, Hinari and Elsevier’s Scopus for key words such as central serous retinopathy, update, latest discovery and new treatment modalities.
Results: Thirteen relevant peer reviewed articles were downloaded of which nine had direct bearing with the objective of this article. In addition, two textbooks were reviewed to complement available information.
References
Sahu C. Comprehensive note in ophthalmology. Jaypee Publishers. New Delhi. 2011: 598-602.
Fineman MS. RetinaA: colour atlas and synopsis of clinical ophthalmology. Wolters Kluver Publisher, India 2012: 78-88.
Thomas VR, Dijk VE, Yzer S, Matsui OK, Jee K, Schlingemann RO, et al. Central serous chorioretinopathy: towards an evidence-based
treatment guideline. https://doi.org/10.1016/ j.preteyeres. accessed on 2019.07.03
Gass M, Donald J. Pathogenesis of disciform detachment of the neuroepithelium: II. Idiopathic central serous choroidopathy. Am J Ophthalmol 1967; 63:587-615
Piccolino FC, de la Longrais RR, Ravera G. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J
Ophthalmol2005;139:87–99
Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefe’s Arch Clin Exp Ophthalmol 1986; 224: 321–324
Danial M, Rosa LS, Dijk HC, Lebriz A, Sascha F, Carel BH, et al. Genetic Risk Factors in Acute Central Serous Chorioretinopathy. Retina 2018;
: 1-8
Chatziralli I, VlachodimitropoulouA ,Daoula C, Vrettou C, Galani E, Theodossiadis G, et al. Eplerenone in the treatment of central serous
chorioretinopathy: a review of the literature. Int J Retin Vitr 2018; 4:33-37.
Singh RP, Sears JE, Bedi R, Schachat AP, Ehlers JP, Kaiser PK. Oral eplerenone for the management of chronic central serous chorioretin-opathy. Int J Ophthalmol2015;8:310– 314
